In order to understand better how gliotic wound tissue of the CNS can be manipulated in order to allow for improved regeneration following CNS trauma or disease, the goals of the experiments described in this proposal are to understand the mechanisms that trigger astrocytes to become reactive and how to modify astrogliosis in order to overcome the repulsive elements made by reactive cells. We have discovered that insoluble B-amyloid (B-AP) peptides when placed on nitrocellulose into the neonatal rat cortex or when used as a substrate in vitro, trigger the increased synthesis by reactive astroglia of a potent neurite repulsive chondroitin sulfate proteoglycan (CS-PG) containing matrix that is deposited over the surface of the peptide. We will use these assays to test for regional and age specificity of the astroglial response to learn whether all types of astrocytes from various regions of the CNS respond equally to the gliotic trigger. We will study whether various cytokines and trophic factors can modify the production of inhibitory ECM stimulated by B-AP or other potential gliosis triggers. Modifications with chondroitinase or antibodies of the inhibitory factors in the matrix made by reactive astrocytes and culture of neurons on the treated or untreated matrix or on top of the reactive cells themselves will allow us to determine.-whether the reactive cells or the reactive matrix can support robust axonal outgrowth once the suspected inhibitor is nullified. We will purify and characterize in substrate assays the B-AP induced gliotic matrix and compare it to purified inhibitory PG's induced in vivo by trauma. We will generate antibodies specific to the most actively inhibitory PG elements for use in a variety of future experiments. Experiments are planned to nullify the reactive glial matrix inhibitor with the use of enzymes or antibodies in two models of regeneration through the glial scar in vivo. Identification and modification of the molecular components in the scar that give rise to the growth refractory gliotic state will allow us to suggest strategies for enhancing regeneration in situations where gliosis is a barrier to regeneration.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS025713-10
Application #
2332949
Study Section
Neurology B Subcommittee 2 (NEUB)
Program Officer
Cheung, Mary Ellen
Project Start
1988-02-01
Project End
2000-01-31
Budget Start
1997-02-01
Budget End
1998-01-31
Support Year
10
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Tran, Amanda Phuong; Sundar, Sapna; Yu, Meigen et al. (2018) Modulation of Receptor Protein Tyrosine Phosphatase Sigma Increases Chondroitin Sulfate Proteoglycan Degradation through Cathepsin B Secretion to Enhance Axon Outgrowth. J Neurosci 38:5399-5414
Luo, Fucheng; Tran, Amanda Phuong; Xin, Li et al. (2018) Modulation of proteoglycan receptor PTP? enhances MMP-2 activity to promote recovery from multiple sclerosis. Nat Commun 9:4126
Cregg, Jared M; Chu, Kevin A; Hager, Lydia E et al. (2017) A Latent Propriospinal Network Can Restore Diaphragm Function after High Cervical Spinal Cord Injury. Cell Rep 21:654-665
Cregg, Jared M; Chu, Kevin A; Dick, Thomas E et al. (2017) Phasic inhibition as a mechanism for generation of rapid respiratory rhythms. Proc Natl Acad Sci U S A 114:12815-12820
Johnsen, Dustin; Olivas, Antoinette; Lang, Bradley et al. (2016) Disrupting protein tyrosine phosphatase ? does not prevent sympathetic axonal dieback following myocardial infarction. Exp Neurol 276:1-4
Filous, Angela R; Silver, Jerry (2016) Neurite Outgrowth Assay. Bio Protoc 6:
Filous, Angela R; Silver, Jerry (2016) ""Targeting astrocytes in CNS injury and disease: A translational research approach"". Prog Neurobiol 144:173-87
DePaul, Marc A; Palmer, Marc; Lang, Bradley T et al. (2015) Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury. Sci Rep 5:16795
Vadivelu, Sudhakar; Stewart, Todd J; Qu, Yun et al. (2015) NG2+ progenitors derived from embryonic stem cells penetrate glial scar and promote axonal outgrowth into white matter after spinal cord injury. Stem Cells Transl Med 4:401-11
Gardner, R T; Wang, L; Lang, B T et al. (2015) Targeting protein tyrosine phosphatase ? after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias. Nat Commun 6:6235

Showing the most recent 10 out of 62 publications